23-Apr-2014 - Novartis has agreed to acquire GlaxoSmithKline’s oncology pipeline for as much as $16bn, while GSK will acquire Novartis’ vaccine business, excluding the flu vaccines, for as much as $7bn.
News in brief
22-Apr-2014 - RNA interference (RNAi) developers that saw stock prices fall after Novartis pulled out of the market last week have reiterated their belief in the therapeutic and revenue potential of gene silencing drugs.
15-Apr-2014 - Hovione has obtained a US patent for a cheap capsule-based dry powder inhaler that it claims is cheaper for manufacturers to produce and easier for patients to use.
09-Apr-2014 - Recent outbreaks of a strain of meningitis, known as “serogroup B” or “MenB”, on US college campuses have caused both Pfizer and Novartis to develop new vaccines.
08-Apr-2014 - Molecular Profiles has invested in hot melt extrusion (HME) and nano milling capabilities citing client demand for improving the bioavailablity of drugs.
08-Apr-2014 - A consortium developing treatments for children infected by parasitic worms has signed up Brazilian drugmaker Fiocruz to support upcoming clinical trials.
02-Apr-2014 - A US FDA review panel has recommended that Afrezza be approved and concluded that the technology used to deliver MannKind's inhalable insulin does not damage airways or lung cells.
01-Apr-2014 - An intracochlear drug delivery implant could be powered over several months by a biodegradable battery according to an expert.
Drug Delivery: Featured news
Senior VP Global Vusiness Development & Marketing, Catalent
Neurotech's Encapsulated Cell Technology (ECT) platform receives a boost with the hire of a new Executive Chairman, and MicroBiome has a new CEO - Welcome to in-Pharmatechnologist's People on the Move.